Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.08.19
第四届董事会第五次聚会决议通告
2017.08.19
2017年半年度财务报告
2017.08.19
关于全资子公司对外投资的完成通告
2017.08.19
2017年半年度召募资金存放与使用情形的专项报告
2017.08.19
第四届监事会第四次聚会决议通告
2017.08.16
关于妄想刊行股份购置资产的停牌希望通告
2017.08.15
第四届监事会第三次聚会决议通告
2017.08.15
关于向中行申请授信额度安排与切分暨为全资子公司提供反担保的通告
2017.08.15
中天堂富证券有限公司关于公司使用部分超募资金永世性增补流动资金的核查意见
2017.08.15
关于使用部分超募资金永世性增补流动资金的通告
第一页
上一页
68
69
70
71
72
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】